Referencias
1.
Xu J, Li G, Wang P et al. Renalase is a
novel, soluble monoamine oxidase that
regulates cardiac function and blood pressure. The
Journal Of Clinical Investigation 2005; 115: 1275-1280.
2.
Guyton AC, Hall JE.
Tratado de Fisiología Médica .
Philadelphia, Elsevier Saunders, 2006.
3.
Go AS,
Chertow GM, Fan D et al. Chronic Kidney Disease and the
Risks of Death Cardiovascular Events, and
Hospitalization. N Engl J Med 2004;
351: 1296-1305.
4.
Anavekar NS, Mc Murray JJ, Velazquez EJ et al. Relation
between renal dysfunction and cardiovascular outcomes
after myocardial infarction. N Engl J Med 2004; 351:
1285-1295.
5.
Marinovich S, Lavorato C, Celia E et al. Registro
argentino de Diálisis Crónica 2004/2005. Publicado
página Web SAN (Sociedad Argentina de Nefrología).
www.san.org.ar/docs/registros/dc/diálisis.
6.
The
Task Force for the Management of Arterial Hypertension
of the European Society of Hypertension (ESH) and of the
European Society of Cardiology (ESC) 2007. Guidelines
for the Management of Arterial Hypertension. J
Hypertension 2007; 25: 1105-1187.
7.
Boomsma
F, Tipton K. Renalase, a catecholamine-metabolizing
enzyme? Journal of Neural Transmission 2007; 114:
775-776.
8.
DiBona
Gerald F. Neural Control of Renal Function:
Cardiovascular Implications. Hypertension 1989; 13:
539-548.
9.
Ishii M, Ikeda T, Takagi M et al.
Elevated plasma catecholamines in
hypertensives with primary glomerular diseases.
Hypertension 1983; 5: 545-551.
10.
Schlaich M, Socratous F, Hennebry S et al. Sympathetic
Activation in Chronic Renal Failure. J Am Soc Nephrol
2009; 20: 933-939.
11.
Vaziri
ND. Effect of chronic renal failure on nitric oxide
metabolism. Am J Kidney Dis 2001; 38: S74-S79.
12.
Coverse
RL Jr, Jacobsen TN, Toto RD et al. Sympathetic
overactivity in patients with chronic renal failure. N
Eng J Med 1992; 327: 1912-1918.
13.
Hausberg M, Kosch M, Harmeling P et al. Sympathetic
Nerve activity in End-stage renal disease. Circulation
2002; 106: 1974-1979.
14.
Koomans HA, Blankestijn PJ, Loles JA.
Sympathetic hyperactivity in
chronic renal failure: a wake-up call. J Am Soc Nephrol
2004; 15: 524-537.
15.
Joles
JA, Koomans HA. Causes and Consequences of Increased
Sympathetic Activity in Renal Disease. Hypertension
2004; 43: 699-706.
16.
Strausberg RL, Feingold EA, Klausner RD.
The mammalian gene collection.
Science 1999; 286: 455-457.
17.
National Center for Biotechnology Information. Maryland
– USA. C10orf59 chromosome 10 open reading frame 59.
18.
Desir
G, Regulation of blood pressure and cardiovascular
function by renalase. Kidney International 2009; 76:
366-370.
19.
Binda C, Mattevi A, Edmosnton DE.
Structure-function relationships in
flavoenzyme dependent amine oxidations: a comparison of
polyamine oxidase and monoamine oxidase. J Biol Chem
2002; 277: 23973-23976.
20.
Li G, Xu J, Wang P et al.
Catecholamines Regulate the Activity,
Secretion and Synthesis of Renalase. Circulation 2008;
117: 1277-1282.
21.
Zhao Q, Fan Z, He J et al.
Renalase gene is a novel
susceptibility gene for essential hypertension: a
two-stage association study in northern Han Chinese
population. J Mol Med 2007; 85: 877-885.
